• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Emergency

Delayed endovascular thrombectomy associated with greater clinical benefit among patients with mismatch imaging profiles in treatment of subacute ischemic stroke

byYuchen DaiandMichael Pratte
July 27, 2021
in Emergency, Hematology, Imaging and Intervention, Neurology
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. The findings supported the use of endovascular thrombectomy in patients who met criteria for either the clinical or target perfusion imaging mismatch profiles, who presented within the 6- to 24-hour since last known well treatment interval for endovascular thrombectomy.

2. The same clinical benefits and reduction in disability associated with endovascular thrombectomy was not observed among patients with underdetermined imaging profiles where further studies are required.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Although the use of intravenous thrombolytics has been firmly established as the main treatment for acute ischemic stroke presenting within 4.5 hours of symptoms onset, the optimal imaging approach for identifying patients who may benefit from endovascular thrombectomy (EVT), a neurointerventional procedure, past 6 hours of symptoms onset is not well established. This pooled analysis of 6 randomized clinical trials (RCTs) as part of the AURORA Collaboration sought to evaluate the therapeutic benefits of EVT among 3 patient subcohorts with the following baseline imaging profiles: (1) clinical mismatch patients who met the imaging criteria used in the DAWN study (Diffusion Weighted Imaging or Computerized Tomography Perfusion Assessment With Clinical Mismatch in the Triage of Wake Up and Late Presenting Strokes Undergoing Neurointervention), (2) target perfusion mismatch patients who met the imaging criteria used in the DEFUSE 3 study (Endovascular Therapy Following Imaging Evaluation for Ischemic Stroke 3), and (3) undetermined imaging mismatch patients where no adequate perfusion study was performed. The main outcome and measure of the analysis was reduction in disability measured by the modified Rankin Scale at 90 days across the subcohorts and further stratified into 3 acute treatment intervals (tercile 1, 360-574 minutes [6.0-9.5 hours]; tercile 2, 575-762 minutes [9.6-12.7 hours]; and tercile 3, 763-1440 minutes [12.8-24.0 hours]). Among 505 pooled patients with ischemic stroke, treatment via EVT was associated with a reduction in disability among patients in the clinical mismatch (clinical defect vs size of early infarction) and target perfusion mismatch (size of perfusion lesion vs size of early infarction) subcohorts and not observed in stroke patients with an undetermined imaging profile. Thus, performance of EVT provided greater clinical benefit among patients with either of the mismatch imaging profiles compared to those with an undetermined imaging profile. These findings supported the use of EVT in patients who met criteria for either the clinical or target perfusion imaging mismatch profiles who presented within the 6- to 24-hour treatment interval for EVT. Further studies are required to assess and validate the use of EVT among patients with underdetermined imaging profiles. A limitation of this study was the exclusion of patients who received EVT treatment within 6 hours after stroke onset, limiting the generalizability of the study results.

Click to read the study in JAMA Neurology

Click to read an accompanying editorial in JAMA Neurology

Relevant Reading: Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct

RELATED REPORTS

#VisualAbstract: Surgical revascularization with great saphenous vein is superior to endovascular therapy for chronic limb-threatening ischemia

#VisualAbstract: Intensive blood pressure control post-endovascular thrombectomy after acute ischemic stroke linked with worse clinical outcomes

Intensive blood pressure control post-endovascular thrombectomy after acute ischemic stroke linked with worse clinical outcomes

In-Depth [randomized controlled trial]: This pooled analysis of 6 RCTs as part of the AURORA (Analysis of Pooled Data from Randomized Studies of Thrombectomy More Than 6 Hours After Last Known Well) Collaboration collectively enrolled 505 eligible patients. Among them, 266 (mean [SD] age, 68.4 [13.8] years; 146 women [54.9%]) were assigned to the EVT cohort and 239 (mean [SD] age, 68.7 [13.7] years; 126 men [52.7%]) were assigned to the control cohort. RCTs on endovascular stroke therapy published between January 2010 and March 2021 were identified via online database search and pooled data was analyzed using mixed-effects modeling with fixed effects for parameters of interest. Inclusion criteria included patients with ischemic stroke who were randomized between 6 and 24 hours after they were last known well. Among 295 patients in the clinical mismatch subcohort, EVT was associated with reductions in disability at 90 days vs no EVT (OR, 3.57; 95%CI, 2.29-5.57; P < .001). Similar reductions in disability associated with EVT were also observed in 359 patients in the target perfusion mismatch subcohort (OR, 3.13; 95%CI, 2.10-4.66; P = .001). Furthermore, clinical benefits of statistical significance were observed in all 3 terciles among both subcohorts, with the highest OR observed for tercile 3 (clinical mismatch subcohort, OR, 4.95; 95%CI, 2.20-11.16; P < .001; target perfusion mismatch subcohort, OR, 5.01; 95%CI, 2.37-10.60; P < .001). Furthermore, 132 patients (26.1%) had an undetermined imaging profile with no significant clinical benefit from treatment (OR, 1.59; 95%CI, 0.82-3.06; P = .17). Finally, the interaction between treatment effects for the mismatch subcohorts compared to the undetermined profile subcohort was statically significant (OR, 2.28; 95%CI, 1.11-4.70; P = .03).

Image: PD

©2021 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: embolic strokeendovascular therapyendovascular thrombectomyischemic stroke
Previous Post

#VisualAbstract: Ipatasertib plus abiraterone improves survival in PTEN-negative prostate cancer patients compared to abiraterone alone

Next Post

Inactivated whole-virion SARS-CoV-2 vaccine reduces rates of symptomatic COVID-19 infections

RelatedReports

#VisualAbstract: Surgical revascularization with great saphenous vein is superior to endovascular therapy for chronic limb-threatening ischemia
StudyGraphics

#VisualAbstract: Surgical revascularization with great saphenous vein is superior to endovascular therapy for chronic limb-threatening ischemia

December 28, 2022
#VisualAbstract: Intensive blood pressure control post-endovascular thrombectomy after acute ischemic stroke linked with worse clinical outcomes
StudyGraphics

#VisualAbstract: Intensive blood pressure control post-endovascular thrombectomy after acute ischemic stroke linked with worse clinical outcomes

November 24, 2022
Stroke expansion following intra-arterial therapy may explain worse outcomes
Cardiology

Intensive blood pressure control post-endovascular thrombectomy after acute ischemic stroke linked with worse clinical outcomes

November 15, 2022
Intensive rehabilitation not superior to traditional therapy for arm function after stroke
Imaging and Intervention

Endovascular therapy associated with slightly improved outcomes in acute stroke patients with distal medium vessel occlusion compared with medical management

November 2, 2022
Next Post
Compliance-linked incentives increase infant immunizations rates in rural India

Inactivated whole-virion SARS-CoV-2 vaccine reduces rates of symptomatic COVID-19 infections

Cancer to surpass heart disease as leading cause of death in the U.S. for higher-income persons

Suicide incidence and risk among patients with head and neck cancer in rural vs urban areas

Being overweight and obese associated with increased incidence of chronic kidney disease

Impact of point-of-care screening for hypertension, diabetes, and progression of chronic kidney disease in rural Manitoba Indigenous communities

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Bisphosphonates, denosumab, abaloparatide, teriparatide, and romosozumab reduce postmenopausal fracture risk
  • Epstein-Barr viral load monitoring reduces risk of post-liver transplant lymphoproliferative disease
  • Homicide deaths are on the rise for children living in the United States
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options